Rare and orphan drug services company Open Orphan (LSE: ORPH) traded at 6.2p on Monday after continuing its strong update with news that it has agreed to sign five new customers to one of its flagship platforms.

The pharmaceutical and biotechnology companies have become early adopters of the Genomic Health DataBANK platform of Open Orphan, which is expected to be completed and launched in Q1 2020. By providing a solution for both pat....